We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Alison Halliday, PhD

Alison Halliday, PhD profile page

Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.

Got a Question for Alison Halliday, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 43
Red cancer cells adhered to a grey surface.

Tumor Heterogeneity: Navigating the Next Frontier in Cancer Research

Some types of cancer are still extremely challenging to successfully treat. Once the disease has spread, it is very hard to cure. This article will explore the various types of tumor heterogeneity, how heterogeneity can impact treatment resistance and its influence on precision medicine.
Representation of cells.
Industry Insight

Maximizing Cell Line Productivity and Efficiency

In this interview, Dr. Tabitha Bullock tells us about some of the key considerations in cell line development and how advances in technology are improving the efficiency and productivity of cell lines.
A cancer cell adhered to a surface.

Harnessing the Power of the Immune System: Advances in Cancer Immunotherapy

This article will explore the role of the immune system and immune evasion in cancer and will discuss how the immune system can be exploited therapeutically and the recent advances in cancer immunotherapy.
A scientist loading samples into a microwell plate.

Advances in CHO Cell Line Development for Biotherapeutics

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.
Two cancer cells with immune cells attached.

Cancer Immunotherapies: Transforming Treatment for Patients

Download this listicle to learn more about immune checkpoint inhibitors and immune system modulators, adoptive cell therapies and oncolytic viral therapy.
A small tube containing liquid is lifted from a container of liquid nitrogen using tweezers.

Frozen in Time: Examining the Latest Frontiers in Cryopreservation Technology

This article highlights recent developments in cryopreservation and the challenges that will need to be overcome to unleash the full potential of the technology.
Blue cells.

Cellular Insights: How Researchers Are Using Cell Models To Study the Mechanisms of Disease

This article will discuss how cell models are enabling researchers to elucidate the underlying biological mechanisms of disease to support diagnostic and therapeutic development.
Dividing cancer cells.

Cancer Genomics: Transforming Diagnosis and Treatment

Download this listicle to learn more about cancer genomics, targeted therapies and advanced diagnostics.
A brain and a tumor under the words "Applications of Liquid Biopsy"

Applications of Liquid Biopsy in Cancer and Beyond

Liquid biopsies are becoming an increasingly important tool for the early detection, prognosis and monitoring of treatment outcomes in cancer, and hold the promise of transforming the management of other diseases in the future.

Four different tablet types sit on or around a white puzzle piece.

Fragment-Based Drug Discovery Enters the Mainstream

This article will discuss the principles of fragment-based drug discovery and will highlight some examples of recent successes in this area.